Stalled Health Care Bill Leaves Drug Makers in Regulatory Limbo
Friday, February 5, 2010 - 00:07
in Health & Medicine
Without the regulatory certainty stemming from the health care bill, drug companies face unpleasant surprises like a heavier tax on foreign income.